Huaheng Biology (688639.SH): The company has not received any investigation or cooperation documents from relevant authorities.

Intelligence Finance APP News, Huaheng Biology (688639.SH) announced in a stock price abnormal movement announcement that the company's production and operation situation is normal, and it has not received any investigation or cooperation investigation documents from relevant authorities regarding the company. The related issues will not have a significant adverse impact on the company's daily operations. The company's board of directors is operating normally, and on June 24, 2026, Mr. Fan Yixian was elected as the chairman of the board of directors and appointed as the general manager of the company. The daily management of the company is handled by the executive team, and other directors and senior management are currently performing their duties normally.